SD-1029
Modify Date: 2024-01-03 14:34:06
SD-1029 structure
|
Common Name | SD-1029 | ||
|---|---|---|---|---|
| CAS Number | 118372-34-2 | Molecular Weight | 639.247 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C25H30Cl2N2O3•2HBr | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SD-1029SD-1029 (NSC 371488) is a potent inhibitor of Stat3 activation, suppresses EGFP-Stat3 nuclear translocation at 10 uM in both BHK-21 and U2-OS cells; inhibits Stat3-mediated antiapoptotic protein expression (Bcl-XL, MCL-1, and survivin), and suppresses phosphotyrosine levels of JAK2; inhibits IL-6 or oncostatin-induced Stat3 nuclear translocation at micromolar range, enhances apoptosis induced by paclitaxel in human cancer cells. |
| Name | 9-(3,4-Dichlorophenyl)-2,7-bis[(dimethylamino)methyl]-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione dihydrobromide |
|---|---|
| Synonym | More Synonyms |
| Description | SD-1029 (NSC 371488) is a potent inhibitor of Stat3 activation, suppresses EGFP-Stat3 nuclear translocation at 10 uM in both BHK-21 and U2-OS cells; inhibits Stat3-mediated antiapoptotic protein expression (Bcl-XL, MCL-1, and survivin), and suppresses phosphotyrosine levels of JAK2; inhibits IL-6 or oncostatin-induced Stat3 nuclear translocation at micromolar range, enhances apoptosis induced by paclitaxel in human cancer cells. |
|---|---|
| References | References 1. Duan Z, et al. Clin Cancer Res. 2006 Nov 15;12(22):6844-52. 2. Yang C, et al. Mol Cancer Ther. 2009 Sep;8(9):2597-605. 3. Che Mat NF, et al. J Interferon Cytokine Res. 2011 Apr;31(4):363-71. View Related Products by Target STAT |
| Molecular Formula | C25H30Cl2N2O3•2HBr |
|---|---|
| Molecular Weight | 639.247 |
| Exact Mass | 636.015686 |
| Hazard Codes | Xi |
|---|
| 9-(3,4-Dichlorophenyl)-2,7-bis[(dimethylamino)methyl]-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione dihydrobromide |
| 1H-Xanthene-1,8(2H)-dione, 9-(3,4-dichlorophenyl)-2,7-bis[(dimethylamino)methyl]-3,4,5,6,7,9-hexahydro-, hydrobromide (1:2) |